Journal of SARS-CoV-2 and Coronavirus Disease
Journal of SARS-CoV-2 and Coronavirus Disease is a newly launched official peer-reviewed open access journal from Wright Academia, a library of medical publications. In this current worldwide outbreak of the novel coronavirus, it is very important to share the information and publish the articles and make it available to readers because sharing of information is crucial to risk assessments and beginning outbreak control activities.
In this journal, we focus on the epidemiology, clinical manifestations, diagnosis, treatments and preventions of this new type of coronavirus.
The journal features original basic & clinical research articles, case reports, review articles, editorials, short communications, study protocols, clinical practice papers, inaugural lectures, letters to the editor, book reviews, conference abstracts, review literature, trial papers, and registered reports.
Submit your manuscript:
The Online Submission System is very much simplified through the process of submission. If you have issues with the submission process or to check your manuscript status, please, contact us (email@example.com)
Review process and Publication time
At present, the submission to first decision time is 3 weeks. The submission to the final decision is 4 weeks. The acceptance to citable online time is 1 week. Apart from this, we have a Fast track process where we offer the fastest possible speed of publication, without compromising on the quality of our peer-review process.
Benefits to authors
We provide many author benefits, such as free PDFs, author copyright policy, and free open access publication.
Some or all of the articles in this journal are indexed in the ICI world of journals, DRJI, Google scholar, Sherpa, Scilit, WorldCat, Crossref. Etc. The articles are published in accordance with the policies and principles of the International Committee of Medical Journal Editors.
All the articles published in this journal are distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
COVID-19 pandemic is leading to a large increase in mortality in the elderly population, with regard to mortality rate observed in patients below 70 years infected with ". Mortality rate is dramatically alarming in the case of patients older than 80 years, about 30% compared to the total population of patients infected by COVID-19. ... read more